5/9
01:46 pm
acad
Rating for ACAD
Low
Report
Rating for ACAD
5/9
01:46 pm
acad
Rating for ACAD
Low
Report
Rating for ACAD
5/9
10:11 am
acad
ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $37.00 price target on the stock.
Medium
Report
ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $37.00 price target on the stock.
5/9
09:52 am
acad
Rating for ACAD
Medium
Report
Rating for ACAD
5/9
09:50 am
acad
Rating for ACAD
Medium
Report
Rating for ACAD
5/9
08:17 am
acad
ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $30.00 price target on the stock.
High
Report
ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $30.00 price target on the stock.
5/9
07:47 am
acad
Rating for ACAD
Medium
Report
Rating for ACAD
5/9
07:47 am
acad
Rating for ACAD
Medium
Report
Rating for ACAD
5/9
06:41 am
acad
Rating for ACAD
Medium
Report
Rating for ACAD
5/9
06:41 am
acad
Rating for ACAD
Medium
Report
Rating for ACAD
5/9
06:40 am
acad
Rating for ACAD
Medium
Report
Rating for ACAD
5/9
06:40 am
acad
Rating for ACAD
Medium
Report
Rating for ACAD
5/6
08:05 am
acad
ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) had its "market perform" rating re-affirmed by analysts at Oppenheimer Holdings Inc.. They now have a $19.00 price target on the stock.
Medium
Report
ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) had its "market perform" rating re-affirmed by analysts at Oppenheimer Holdings Inc.. They now have a $19.00 price target on the stock.
5/6
07:43 am
acad
Rating for ACAD
Low
Report
Rating for ACAD
5/6
07:43 am
acad
Rating for ACAD
Low
Report
Rating for ACAD
4/30
10:27 am
acad
ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $37.00 price target on the stock.
Low
Report
ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $37.00 price target on the stock.
4/30
10:21 am
acad
Rating for ACAD
Low
Report
Rating for ACAD
4/10
10:19 am
acad
ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $37.00 price target on the stock.
Low
Report
ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $37.00 price target on the stock.
4/10
09:32 am
acad
Rating for ACAD
Low
Report
Rating for ACAD
4/9
08:09 am
acad
ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $32.00 price target on the stock.
Low
Report
ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $32.00 price target on the stock.
4/9
06:27 am
acad
Rating for ACAD
Low
Report
Rating for ACAD
4/9
06:27 am
acad
Rating for ACAD
Low
Report
Rating for ACAD
3/25
09:19 am
acad
Rating for ACAD
Low
Report
Rating for ACAD
3/13
12:01 pm
acad
Rating for ACAD
Low
Report
Rating for ACAD
3/13
12:01 pm
acad
Rating for ACAD
Low
Report
Rating for ACAD